Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life.
Saved in:
| Title: | Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life. |
|---|---|
| Authors: | Sitbon, Alexandre1 (AUTHOR), Hauw‑Berlemont, Caroline2 (AUTHOR), Mebarki, Miryam3 (AUTHOR), Heming, Nicholas4 (AUTHOR), Mayaux, Julien5 (AUTHOR), Diehl, Jean‑Luc2,6,7 (AUTHOR), Demoule, Alexandre5 (AUTHOR), Annane, Djillali4 (AUTHOR), Marois, Clémence8,9 (AUTHOR), Demeret, Sophie8,9 (AUTHOR), Weiss, Emmanuel10,11 (AUTHOR), Voiriot, Guillaume12 (AUTHOR), Fartoukh, Muriel12 (AUTHOR), Constantin, Jean‐Michel1 (AUTHOR), Mégarbane, Bruno13 (AUTHOR), Plantefève, Gaëtan14 (AUTHOR), Boucher‑Pillet, Hélène15 (AUTHOR), Churlaud, Guillaume15 (AUTHOR), Cras, Audrey3,16 (AUTHOR), Maheux, Camille15 (AUTHOR) |
| Source: | Stem Cell Research & Therapy. 4/19/2024, Vol. 15, p1-9. 9p. 2 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
| ISSN: | 17576512 |
|---|---|
| DOI: | 10.1186/s13287-024-03729-w |
